Studies on antistreptolysin O activity generated in serum by microorganisms.
An antistreptolysin factor (ASF) was generated in normal human serum by the growth of Staph, aureus and Pseud, aeruginosa. Alpha toxin producing strains of the former were usually positive but activity was not restricted to such strains. Positive strains produce cholesterol esterase which was obtained from DEAE-cellulose column fractions of 18 h broth cultures. Antistreptolysin factor develops slowly in serum, being maximal between the 5th and 10th days and is associated with alterations and disappearance of beta lipoproteins on gel electrophoresis. Activity also appeared in beta lipoproteins precipitated from normal serum with dextran sulphate and redissolved in nutrient broth before inoculation with Staph, aureus. The slow appearance of antistreptolysin activity in serum appears to be due to an esterase inhibitor which is present in high concentrations in some sera. Activity is also modified by the production of a staphylococcal fraction capable of binding to the antistreptolysin factor and reducing its activity. It is suggested that antistreptolysin factor which can be demonstrated in small amounts in normal human serum represents a readily available non-specific defence mechanism capable of binding to certain bacterial products and possible to other foreign protein molecules.
D000989:Antistreptolysin / Q000032:analysis* / Q000037:antagonists & inhibitors; D001769:Blood / Q000382:microbiology*; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood; D008077:Lipoproteins, LDL / Q000032:analysis; D011550:Pseudomonas aeruginosa; D013211:Staphylococcus aureus; D002787:Sterol Esterase / Q000037:antagonists & inhibitors / Q000097:blood
D008077:Lipoproteins, LDL; D000989:Antistreptolysin; D002787:Sterol Esterase